1887
Preview this article:
Zoom in
Zoomout

Is nalidixic acid resistance linked to clinical virulence in serovar Typhi infections?, Page 1 of 1

| /docserver/preview/fulltext/jmm/57/8/1046-1.gif

There is no abstract available for this article.
Use the preview function to the left.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.47822-0
2008-08-01
2020-08-09
Loading full text...

Full text loading...

/deliver/fulltext/jmm/57/8/1046.html?itemId=/content/journal/jmm/10.1099/jmm.0.47822-0&mimeType=html&fmt=ahah

References

  1. Bland J. M., Altman D. G. 1998; Survival probabilities (the Kaplan-Meier method). BMJ 317:1572 [CrossRef]
    [Google Scholar]
  2. Bland J. M., Altman D. G. 2004; The logrank test. BMJ 328:1073 [CrossRef]
    [Google Scholar]
  3. Freedman D. O., Weld L. H., Kozarsky P. E., Fisk T., Robins R., von Sonnenberg F., Keystone J. S., Pandey P., Cetron M. S. other authors 2006; Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med 354:119–130 [CrossRef]
    [Google Scholar]
  4. Hakanen A., Kotilainen P., Jalava J., Siitonen A., Huovinen P. 1999; Detection of decreased fluoroquinolone susceptibility in Salmonellas and validation of nalidixic acid screening test. J Clin Microbiol 37:3572–3577
    [Google Scholar]
  5. Kadhiravan T., Wig N., Kapil A., Kabra S. K., Renuka K., Misra A. 2005; Cinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi . BMC Infect Dis 5:37 [CrossRef]
    [Google Scholar]
  6. Nkemngu N. J., Asonganyi E. D., Njunda A. L. 2005; Treatment failure in a typhoid patient infected with nalidixic acid resistant S. enterica serovar Typhi with reduced susceptibility to ciprofloxacin: a case report from Cameroon. BMC Infect Dis 5:49 [CrossRef]
    [Google Scholar]
  7. Parry C. M. 2004; The treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever in Viet Nam. Trans R Soc Trop Med Hyg 98:413–422 [CrossRef]
    [Google Scholar]
  8. Parry C. M., Hien T. T., Dougan G., White N. J., Farrar J. J. 2002; Typhoid fever. N Engl J Med 347:1770–1782 [CrossRef]
    [Google Scholar]
  9. Rahman M., Siddique A. K., Shoma S., Rashid H., Salam M. A., Ahmed Q. S., Nair G. B., Breiman R. F. 2006; Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh. Epidemiol Infect 134:433–438
    [Google Scholar]
  10. Renuka K., Sood S., Das B. K., Kapil A. 2005; High-level ciprofloxacin resistance in Salmonella enterica serotype Typhi in India. J Med Microbiol 54:999–1000 [CrossRef]
    [Google Scholar]
  11. Slinger R., Desjardins M., McCarthy A. E., Ramotar K., Jessamine P., Guibord C., Toye B. 2004; Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility. BMC Infect Dis 4:36 [CrossRef]
    [Google Scholar]
  12. Wain J., Diep T. S., Ho V. A., Walsh A. M., Nguyen T. T., Parry C. M., White N. J. 1998; Quantitation of bacteria in blood of typhoid fever patients and relationship between counts and clinical features, transmissibility, and antibiotic resistance. J Clin Microbiol 36:1683–1687
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.47822-0
Loading
/content/journal/jmm/10.1099/jmm.0.47822-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error